About AtriCure
AtriCure is a company based in Mason (United States) founded in 2000. The company has 1,300 employees as of December 31, 2024. AtriCure has completed 4 acquisitions, including Estech, SentreHEART and nContact. AtriCure operates in a competitive market with competitors including AtaCor Medical, Kestra Medical Technologies, CardioFocus, Biosense Webster and EBR Systems, among others.
- Headquarter Mason, United States
- Employees 1300 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Atricure, Inc.
-
Annual Revenue
$465.31 M (USD)16.55as on Dec 31, 2024
-
Net Profit
-$44.7 M (USD)-46.85as on Dec 31, 2024
-
EBITDA
-$9.28 M (USD)43as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
1300
as on Dec 31, 2024
-
Investments & Acquisitions
Estech
& 3 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of AtriCure
AtriCure is a publicly listed company on the NASDAQ with ticker symbol ATRC in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of AtriCure
Unlock access to complete
Unlock access to complete
Funding Insights of AtriCure
Detailed funding history for AtriCure
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AtriCure
AtriCure has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Estech, SentreHEART and nContact.
Investment portfolio details for AtriCure
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Suture-based devices for soft tissue closure are developed.
|
Locked | Locked | 2005 | Locked | |
|
Epicardial ablation devices
|
Locked | Locked | 2005 | Locked | |
|
Cardiac ablation devices for atrial fibrillation treatment are developed.
|
Locked | Locked | 2005 | Locked |
Complete acquisition details for AtriCure
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - AtriCure
Detailed financials for AtriCure
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Atricure Comparisons
Peer comparison for AtriCure
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AtriCure
AtriCure operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AtaCor Medical, Kestra Medical Technologies, CardioFocus, Biosense Webster and EBR Systems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An implantable pacemaker system is developed for cardiac pacing therapy.
|
|
| Locked | Locked | Locked |
Medical devices are developed to support cardiovascular patients at risk.
|
|
| Locked | Locked | Locked |
Endoscopic catheter for atrial fibrillation ablation is developed.
|
|
| Locked | Locked | Locked |
Mapping catheters for cardiac arrhythmia treatment are developed.
|
|
| Locked | Locked | Locked |
Wireless cardiac pacing devices are developed for left ventricle stimulation.
|
Detailed competitors of AtriCure
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Atricure
Complete news archive for AtriCure
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AtriCure
AtriCure was founded in 2000.
AtriCure is headquartered in Mason, United States. It is registered at Mason, Ohio, United States.
As of Dec 31, 2024, the latest employee count at AtriCure is 1,300.
Annual revenue of AtriCure is $465.31M as on Dec 31, 2024.
AtriCure was founded in 2000 and is headquartered in Mason, United States. Products focused on cardiac surgery, such as ablation devices, left atrial appendage occlusion tools, and intraoperative testing equipment, are offered in the medical device sector. The company was taken public in 2005. In October 2015, nContact, a developer of ablation solutions, was acquired to expand capabilities. Operations center on therapies for atrial fibrillation.
AtriCure's top competitors include AtaCor Medical, CardioFocus and Kestra Medical Technologies.
Yes, AtriCure is publicly traded on NASDAQ under the ticker symbol ATRC.
AtriCure has made 4 acquisitions, including Estech, SentreHEART, and nContact.
The ticker symbol of AtriCure is ATRC on NASDAQ.